Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice

Lili A. Barouch, Dan E. Berkowitz, Robert W. Harrison, Christopher P. O'Donnell, Joshua Hare

Research output: Contribution to journalArticle

243 Citations (Scopus)

Abstract

Background - Whether left ventricular hypertrophy (LVH) in obesity results from increased hemodynamic load or altered neurohormonal signaling remains controversial. Dysregulation of leptin, a neurohormone essential to energy homeostasis, is implicated in the pathogenesis of obesity. Because leptin has cardiovascular bioactivity, we hypothesized that disruption of leptin signaling mediates the development of obesity-associated LVH. Methods and Results - We measured left ventricular (LV) wall thickness and LV mass with echocardiography in mice lacking leptin (ob/ob, n = 15) or functional receptor (db/db, n = 10) and controls at 2, 4, and 6 months of age. None of the mice had LVH at 2 months. Progressive obesity developed in ob/ob and db/db mice. At 6 months, LVH occurred in ob/ob and db/db compared with controls. We observed corresponding myocyte hypertrophy by light microscopy. To separate the direct contribution of leptin deficiency from mechanical effects of obesity, we induced weight loss in 6- to 8-month-old ob/ob mice either by leptin infusion or caloric restriction. Mice in both groups lost similar weight compared with placebo-treated controls. Leptin infusion completely reversed the increase in wall thickness with partial resolution of myocyte hypertrophy, whereas calorie-restricted mice had no decrease in wall thickness and a lesser change in myocyte size. Conclusions - Together these data show that the effect of leptin on LV remodeling is not attributable to weight loss alone, indicating that leptin has antihypertrophic effects on the heart, either directly or through a leptin-regulated neurohumoral pathway. Disruption of leptin signaling may represent a novel mechanism in LVH and related cardiovascular disorders.

Original languageEnglish
Pages (from-to)754-759
Number of pages6
JournalCirculation
Volume108
Issue number6
DOIs
StatePublished - Aug 12 2003
Externally publishedYes

Fingerprint

Cardiomegaly
Leptin
Body Weight
Left Ventricular Hypertrophy
Obesity
Muscle Cells
Hypertrophy
Weight Loss
Caloric Restriction
Ventricular Remodeling
Neurotransmitter Agents
Echocardiography
Microscopy
Homeostasis
Hemodynamics
Placebos
Light
Weights and Measures

Keywords

  • Echocardiography
  • Hypertrophy
  • Leptin
  • Obesity

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. / Barouch, Lili A.; Berkowitz, Dan E.; Harrison, Robert W.; O'Donnell, Christopher P.; Hare, Joshua.

In: Circulation, Vol. 108, No. 6, 12.08.2003, p. 754-759.

Research output: Contribution to journalArticle

Barouch, Lili A. ; Berkowitz, Dan E. ; Harrison, Robert W. ; O'Donnell, Christopher P. ; Hare, Joshua. / Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. In: Circulation. 2003 ; Vol. 108, No. 6. pp. 754-759.
@article{f5d22303fa8b4db9b2f1125847233108,
title = "Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice",
abstract = "Background - Whether left ventricular hypertrophy (LVH) in obesity results from increased hemodynamic load or altered neurohormonal signaling remains controversial. Dysregulation of leptin, a neurohormone essential to energy homeostasis, is implicated in the pathogenesis of obesity. Because leptin has cardiovascular bioactivity, we hypothesized that disruption of leptin signaling mediates the development of obesity-associated LVH. Methods and Results - We measured left ventricular (LV) wall thickness and LV mass with echocardiography in mice lacking leptin (ob/ob, n = 15) or functional receptor (db/db, n = 10) and controls at 2, 4, and 6 months of age. None of the mice had LVH at 2 months. Progressive obesity developed in ob/ob and db/db mice. At 6 months, LVH occurred in ob/ob and db/db compared with controls. We observed corresponding myocyte hypertrophy by light microscopy. To separate the direct contribution of leptin deficiency from mechanical effects of obesity, we induced weight loss in 6- to 8-month-old ob/ob mice either by leptin infusion or caloric restriction. Mice in both groups lost similar weight compared with placebo-treated controls. Leptin infusion completely reversed the increase in wall thickness with partial resolution of myocyte hypertrophy, whereas calorie-restricted mice had no decrease in wall thickness and a lesser change in myocyte size. Conclusions - Together these data show that the effect of leptin on LV remodeling is not attributable to weight loss alone, indicating that leptin has antihypertrophic effects on the heart, either directly or through a leptin-regulated neurohumoral pathway. Disruption of leptin signaling may represent a novel mechanism in LVH and related cardiovascular disorders.",
keywords = "Echocardiography, Hypertrophy, Leptin, Obesity",
author = "Barouch, {Lili A.} and Berkowitz, {Dan E.} and Harrison, {Robert W.} and O'Donnell, {Christopher P.} and Joshua Hare",
year = "2003",
month = "8",
day = "12",
doi = "10.1161/01.CIR.0000083716.82622.FD",
language = "English",
volume = "108",
pages = "754--759",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice

AU - Barouch, Lili A.

AU - Berkowitz, Dan E.

AU - Harrison, Robert W.

AU - O'Donnell, Christopher P.

AU - Hare, Joshua

PY - 2003/8/12

Y1 - 2003/8/12

N2 - Background - Whether left ventricular hypertrophy (LVH) in obesity results from increased hemodynamic load or altered neurohormonal signaling remains controversial. Dysregulation of leptin, a neurohormone essential to energy homeostasis, is implicated in the pathogenesis of obesity. Because leptin has cardiovascular bioactivity, we hypothesized that disruption of leptin signaling mediates the development of obesity-associated LVH. Methods and Results - We measured left ventricular (LV) wall thickness and LV mass with echocardiography in mice lacking leptin (ob/ob, n = 15) or functional receptor (db/db, n = 10) and controls at 2, 4, and 6 months of age. None of the mice had LVH at 2 months. Progressive obesity developed in ob/ob and db/db mice. At 6 months, LVH occurred in ob/ob and db/db compared with controls. We observed corresponding myocyte hypertrophy by light microscopy. To separate the direct contribution of leptin deficiency from mechanical effects of obesity, we induced weight loss in 6- to 8-month-old ob/ob mice either by leptin infusion or caloric restriction. Mice in both groups lost similar weight compared with placebo-treated controls. Leptin infusion completely reversed the increase in wall thickness with partial resolution of myocyte hypertrophy, whereas calorie-restricted mice had no decrease in wall thickness and a lesser change in myocyte size. Conclusions - Together these data show that the effect of leptin on LV remodeling is not attributable to weight loss alone, indicating that leptin has antihypertrophic effects on the heart, either directly or through a leptin-regulated neurohumoral pathway. Disruption of leptin signaling may represent a novel mechanism in LVH and related cardiovascular disorders.

AB - Background - Whether left ventricular hypertrophy (LVH) in obesity results from increased hemodynamic load or altered neurohormonal signaling remains controversial. Dysregulation of leptin, a neurohormone essential to energy homeostasis, is implicated in the pathogenesis of obesity. Because leptin has cardiovascular bioactivity, we hypothesized that disruption of leptin signaling mediates the development of obesity-associated LVH. Methods and Results - We measured left ventricular (LV) wall thickness and LV mass with echocardiography in mice lacking leptin (ob/ob, n = 15) or functional receptor (db/db, n = 10) and controls at 2, 4, and 6 months of age. None of the mice had LVH at 2 months. Progressive obesity developed in ob/ob and db/db mice. At 6 months, LVH occurred in ob/ob and db/db compared with controls. We observed corresponding myocyte hypertrophy by light microscopy. To separate the direct contribution of leptin deficiency from mechanical effects of obesity, we induced weight loss in 6- to 8-month-old ob/ob mice either by leptin infusion or caloric restriction. Mice in both groups lost similar weight compared with placebo-treated controls. Leptin infusion completely reversed the increase in wall thickness with partial resolution of myocyte hypertrophy, whereas calorie-restricted mice had no decrease in wall thickness and a lesser change in myocyte size. Conclusions - Together these data show that the effect of leptin on LV remodeling is not attributable to weight loss alone, indicating that leptin has antihypertrophic effects on the heart, either directly or through a leptin-regulated neurohumoral pathway. Disruption of leptin signaling may represent a novel mechanism in LVH and related cardiovascular disorders.

KW - Echocardiography

KW - Hypertrophy

KW - Leptin

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=0042018759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042018759&partnerID=8YFLogxK

U2 - 10.1161/01.CIR.0000083716.82622.FD

DO - 10.1161/01.CIR.0000083716.82622.FD

M3 - Article

VL - 108

SP - 754

EP - 759

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 6

ER -